Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenNIDAClinical trial: Optional / allowed

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

National Institute on Drug Abuse (NIDA) · NIH Institute/Center · RFA-DA-25-060

Source: Grants.gov · View original posting ↗

Award
Up to $1.5M
Deadline
Mar 5, 2027
Letter of intent
Mechanism
Duration
Expected awards
Funding cycle
One-time
Open date
Jan 17, 2024
Total funding
Clinical trial
Optional / allowed
GovernmentSmall businessHigher educationNonprofitForeign entities

Research areas

Therapeutics & drug discoveryPrevention & risk factors

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.